Author | Symantha Melemed, PhD | OncLive

Author | Symantha Melemed, PhD

Articles

The Long-Term Potential of Olaratumab in Soft Tissue Sarcoma

May 08, 2017

Video

Symantha Melemed, global product team lead, Oncology Business Unit, Eli Lilly & Company, discusses the impact of the FDA approval of olaratumab (Lartruvo) in patients with soft tissue sarcoma

x